Top Pharmaceuticals companies in Denmark by Price to Sales Ratio (P/S)

This ranking features the top 17 Pharmaceuticals companies in Denmark ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 70.64, for January 15, 2025.
#
Name
Price to Sales Ratio (P/S)
Reported Date
Stock Price
Change
Price (30 days) Country
1

865.40

Jan. 14, 2025 USD 3.98 0.01%

Denmark

2

133.44

Jan. 14, 2025 USD 95.84 0.08%

Denmark

3

49.14

Jan. 14, 2025 USD 91.43 -1.85%

Denmark

4

38.91

Jan. 14, 2025 USD 0.57 1.47%

Denmark

5

20.89

Jan. 14, 2025 USD 70.50 0.61%

Denmark

6

19.16

Jan. 14, 2025 USD 0.20 -2.77%

Denmark

7

14.42

Jan. 14, 2025 USD 1.93 -6.19%

Denmark

8

10.53

Jan. 14, 2025 USD 81.56 -2.90%

Denmark

9

9.49

Jan. 14, 2025 USD 54.16 -1.39%

Denmark

10

8.31

Jan. 14, 2025 USD 2.17 5.88%

Denmark

11

6.25

Jan. 14, 2025 USD 20.15 -0.78%

Denmark

12

6.20

Jan. 14, 2025 USD 18.73 1.26%

Denmark

13

6.09

Jan. 14, 2025 USD 109.06 -0.12%

Denmark

14

5.65

Jan. 14, 2025 USD 216.88 1.28%

Denmark

15

3.27

Jan. 14, 2025 USD 0.85 -3.38%

Denmark

16

2.00

Jan. 14, 2025 USD 26.62 -0.36%

Denmark

17

1.77

Jan. 14, 2025 USD 5.46 0.56%

Denmark

Frequently Asked Questions
  • Which Pharmaceuticals company in Denmark has the highest Price to Sales Ratio (P/S) ?

    The Pharmaceuticals company in Denmark with the highest Price to Sales Ratio (P/S) is FluoGuide A/S (Stockholm Stock Exchange: FLUO.ST) at 865.40.

  • Which Pharmaceuticals company in Denmark has the lowest Price to Sales Ratio (P/S) ?

    The Pharmaceuticals company in Denmark with the lowest Price to Sales Ratio (P/S) is H. Lundbeck A/S (Copenhagen Stock Exchange: HLUN-B.CO) at 1.77.